And it matters because the psychiatric applications of GLP-1 analogs, including emerging evidence for efficacy in addiction, depression, and other conditions, remain largely unexplored through the lens of sex
Other new drug applications for advanced GLP-1 combos are under review at the FDA and EMA in 2025
Statements have not been evaluated by the FDA or any regulatory authority
We need to keep exercising. And people who have been exercising for years will say, I just no longer I don't know, I can't exercise while I'm on it
(b), the inhibitory neurotransmitter, -aminobutyric acid (GABA), and (c), the clinically approved HDAC inhibitor, vorinostat (suberoylanilide hydroxamic acid, SAHA)
Frequently asked questions Most GLP-1 care is built around access to medication